Abstract
Summary: Fumarylacetoacetate fumarylhydrolase (E.C.3.7.1.2.), a liver enzyme involved in tyrosine degradation, is shown to be present in many human tissues and cells including lymphocytes, fibroblasts, and cultured amniotic fluid cells. The enzyme activity in lymphocytes from six patients with hereditary tyrosinemia (hepatorenal type) and fibroblasts from three patients, was found to be less than 10% of the activity in control subjects. In lymphocytes and fibroblasts from the parents (n = 16) of the patients the enzyme values were compatible with a heterozygote genotype. The lymphocyte enzyme pattern of the control subjects (n = 97), is complicated, and indicates possible enzyme variants.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kvittingen, E., Halvorsen, S. & Jellum, E. Deficient Fumarylacetoacetate Fumarylhydrolase Activity in Lymphocytes and Fibroblasts from Patients with Hereditary Tyrosinemia. Pediatr Res 17, 541–544 (1983). https://doi.org/10.1203/00006450-198307000-00005
Issue Date:
DOI: https://doi.org/10.1203/00006450-198307000-00005
This article is cited by
-
MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients
Molecular Biology Reports (2013)
-
Tyrosinemia type I—Diagnostic issues and prenatal diagnosis
The Indian Journal of Pediatrics (2006)
-
Tyrosin�mie Typ I
Monatsschrift Kinderheilkunde (2004)
-
Hereditary tyrosinaemia type I: A long‐term study of the relationship between the urinary excretions of succinylacetone and δ‐aminolevulinic acid
Journal of Inherited Metabolic Disease (1993)
-
Renal failure in adult patients with hereditary tyrosinaemia type I
Journal of Inherited Metabolic Disease (1991)